ArticleNucleic acids research2025
Design of mismatch closure for enhanced specificity in DNA strand displacement reactions.
Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Specific and sensitive DNA hybridization plays a key role in biotechnology, nanotechnology, and medical technology. However, traditional DNA hybridization-based strategies often require careful tuning of the binding affinity of the probe to attain a trade-off between specificity and sensitivity. Herein, we proposed energy barrier-gated dynamic selectivity to overcome this limitation. The mismatch closure-mediated strand displacement reaction (mcSDR) induces structural constraints through helper strand binding at mismatched sites, resulting in the displacement of the mismatch target requires overcoming an additional activation energy barrier, whereas the perfect match target proceeds via a normal pathway. The mcSDR has been thermodynamically and kinetically demonstrated to be able to balance specificity and sensitivity simultaneously. The energy barrier height can be programmably adjusted by design of helper strand and works in synergy with the toehold exchange strategy to achieve multi-parameter optimization. The superior properties of the mcSDR facilitated the identification of 12 mutation types exhibits excellent specificity in 28 clinically relevant single nucleotide variations. By combining polymerase chain reaction, mutations with an abundance of 0.1% were successfully detected in plasmid samples, and a triple mcSDR was successfully constructed. Clinical validation of 95 glioma and 93 colorectal cancer samples showed that IDH1 and KRAS mutations were 100% consistent with Sanger sequencing. The energy barrier-driven identification mechanism and operational simplicity of mcSDR make it promising for wide applications in biomedical research, molecular diagnosis, and precision medicine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.